SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Jones Adrian M (Last) (First) (Middle) C/O GOLDMAN SACHS & CO. LLC 200 WEST STREET (Street) NEW YORK NY 10282 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol T2 Biosystems, Inc. [ TTOO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 06/07/2019
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.54	06/07/2019		A		22,000		(2)	06/07/2029	Common Stock	22,000	$0	22,000	I(1)(2)	See Footnotes(1)(2)

Explanation of Responses:

1. The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.

2. The options to purchase 22,000 shares of common stock of T2 Biosystems, Inc. ("Company") were granted to the Reporting Person, pursuant to the Company's Amended and Restated 2014 Incentive Award Plan under the Company's Non-Employee Director Compensation Program, on June 7, 2019 in his capacity as a director of the Company. The options vest and become exercisable in twelve substantially equal monthly installments commencing on June 7, 2019.The Reporting Person has an understanding with GS Group pursuant to which he holds such options for the benefit of GS Group.

Remarks:

	/s/Jennifer Lee, Attorney-in-fact	06/12/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

The undersigned does hereby make, constitute and appoint each of

Jamison Yardley and Jennifer Lee (and any other employee, of The

Goldman Sachs Group, Inc. (the "Company") or one of its affiliates,

performing the function in connection with which this Power of

Attorney has been granted designated in writing by one of the

attorneys-in-fact), as his true and lawful attorney-in-fact, acting

for him in his respective name, place and stead, whether acting

individually or as a representative of others, to approve, execute

and deliver any documentation required to be made by him under the

Securities Exchange Act of 1934 (as amended, the "Act"), with respect

to securities which may be deemed to be beneficially owned by him

under the Act, such documents to be in such form as such

attorney-in-fact may approve on the undersigned's behalf, such

approval to be conclusively evidenced by the due execution thereof,

and granting unto such attorney-in-fact full power, including

substitution and resubstitution, and authority to act in the premises

as fully and to all intents and purposes as the undersigned might or

could do in person, and hereby ratifies, approves and confirms all

that such attorney-in-fact shall lawfully do or cause to be done by

virtue hereof.

THIS POWER OF ATTORNEY shall remain in full force and effect until

the earlier of (i)

June 11, 2022 and (ii) such time that it is revoked in writing by the

undersigned; provided that in the event the attorney-in-fact ceases

to be an employee of the Company or its affiliates or ceases to

perform the function in connection with which he/she was appointed

attorney-in-fact prior to such time, this Power of Attorney shall

cease to have effect in relation to such attorney-in-fact upon such

cessation but shall continue in full force and effect in relation to

any remaining attorneys-in-fact. The undersigned has the unrestricted

right unilaterally to revoke this Power of Attorney.

This Power of Attorney shall be governed by, and construed in

accordance with, the laws of the State of New York, without regard to

rules of conflicts of law.

IN WITNESS WHEREOF, the undersigned has duly subscribed these

presents as of June 11, 2019.

By: /s/ Adrian Jones

Name: Adrian Jones